• 1
    Enzinger F,Weiss S. Soft Tissue Tumors. 3rd ed. St. Louis, MO: CV Mosby; 1995: 201229.
  • 2
    Yang JC,Chang AE,Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998; 16: 197203.
  • 3
    Pisters PW,Harrison LB,Leung DH,Woodruff JM,Casper ES,Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996; 14: 859868.
  • 4
    Strander H,Turesson I,Cavallin-Stahl E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol. 2003; 42: 516531.
  • 5
    [No authors listed]. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997; 350: 16471654.
  • 6
    Benjamin RS. Evidence for using adjuvant chemotherapy as standard treatment of soft tissue sarcoma. Semin Radiat Oncol. 1999; 9: 349351.
  • 7
    Davis AM,O'Sullivan B,Turcotte R, et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005; 75: 4853.
  • 8
    Cannon CP,Ballo MT,Zagars GK, et al. Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer. 2006; 107: 24552461.
  • 9
    GreeneFL,PageDL,FlemingID, et al., editors. AJCC Cancer Staging Manual.6th ed. New York: Springer; 2002.
  • 10
    Zagars GK,Ballo MT,Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer. 2003; 97: 25302543.
  • 11
    Zagars GK,Ballo MT,Pisters PW,Pollock RE,Patel SR,Benjamin RS. Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2003; 57: 739747.
  • 12
    Zagars GK,Mullen JR,Pollack A. Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1996; 34: 983994.
  • 13
    Pollack A,Zagars GK,Goswitz MS,Pollock RA,Feig BW,Pisters PW. Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation. Int J Radiat Oncol Biol Phys. 1998; 42: 563572.
  • 14
    Guadagnolo BA,Zagars GK,Ballo MT, et al. Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2008; 70: 760765.
  • 15
    Guadagnolo BA,Zagars GK,Ballo MT, et al. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 2007; 69: 11731180.
  • 16
    Zagars GK,Ballo MT,Pisters PW,Pollock RE,Patel SR,Benjamin RS. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys. 2003; 56: 482488.
  • 17
    Ballo MT,Zagars GK. The soft tissue. In: CoxJD,AngKK, eds. Radiation Oncology, Rationale, Technique, Results.8th ed. St. Louis, MO: Mosby; 2003.
  • 18
    Ek H,Albert A. Survivorship Analysis for Clinical Studies. New York: Marcel Dekker; 1991.
  • 19
    Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall; 1991.
  • 20
    Cox D. Regression models and life tables. J R Stat Soc B. 1972; 34: 187220.
  • 21
    U.S. Department of Health and Human Services. National Vital Statistics Reports: 1950-2004. Washington, DC: U.S. Department of Health and Human Services, National Center for Health Statistics; 2006.
  • 22
    Arias E.United States Life Tables, 2000.National Vital Statistics Report. Vol. 51. No. 3. Bethesda, MD: National Center for Health Statistics;2002.
  • 23
    Armitage P,Berry G,Matthews JNS. Statistical methods in epidemiology. In: Statistical Methods in Medical Research. Oxford, UK: Blackwell; 2002: 685689.
  • 24
    Kahn H,Sempos CT. Follow-up studies: person-years. In: Statistical Methods in Epidemiology. New York: Oxford University Press; 1989: 206225.
  • 25
    Taeger D,Sun Y,Keil U,Straif K. A stand-alone windows applications for computing exact person-years, standardized mortality ratios and confidence intervals in epidemiological studies. Epidemiology. 2000; 11: 607608.
  • 26
    Hall E. Radiobiology for the Radiologist. 5th ed. Philadelphia: Lippincott; 2000.
  • 27
    Thompson DE,Mabuchi K,Ron E, et al. Cancer incidence in atomic bomb survivors. II. Solid tumors, 1958-1987. Radiat Res. 1994; 137( 2 suppl): S17S67.
  • 28
    Tokunaga M,Land CE,Tokuoka S,Nishimori I,Soda M,Akiba S. Incidence of female breast cancer among atomic bomb survivors, 1950-1985. Radiat Res. 1994; 138: 209223.
  • 29
    Pierce DA,Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res. 2000; 154: 178186.
  • 30
    Preston DL,Shimizu Y,Pierce DA,Suyama A,Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res. 2003; 160: 381407.
  • 31
    Preston DL,Pierce DA,Shimizu Y,Ron E,Mabuchi K. Dose response and temporal patterns of radiation-associated solid cancer risks. Health Phys. 2003; 85: 4346.
  • 32
    Dores GM,Metayer C,Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol. 2002; 20: 34843494.
  • 33
    Aleman BM,van den Belt-Dusebout AW,Klokman WJ,Van't Veer MB,Bartelink H,van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol. 2003; 21: 34313439.
  • 34
    Travis LB,Fossa SD,Schonfeld SJ, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005; 97: 13541365.
  • 35
    Karlsson P,Holmberg E,Samuelsson A,Johansson KA,Wallgren A. Soft tissue sarcoma after treatment for breast cancer—a Swedish population-based study. Eur J Cancer. 1998; 34: 20682075.
  • 36
    Birgisson H,Pahlman L,Gunnarsson U,Glimelius B. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol. 2005; 23: 61266131.
  • 37
    Boice JDJr,Day NE,Andersen A, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst. 1985; 74: 955975.
  • 38
    van Leeuwen FE,Klokman WJ,Hagenbeek A, et al. Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol. 1994; 12: 312325.
  • 39
    Hodgson DC,Gilbert ES,Dores GM, et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol. 2007; 25: 14891497.
  • 40
    Ng AK,Bernardo MV,Weller E, et al. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002; 100: 19891996.
  • 41
    Swerdlow AJ,Barber JA,Hudson GV, et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol. 2000; 18: 498509.
  • 42
    Brenner DJ,Curtis RE,Hall EJ,Ron E. Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer. 2000; 88: 398406.
  • 43
    Roychoudhuri R,Evans H,Robinson D,Moller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer. 2004; 91: 868872.
  • 44
    Virtanen A,Pukkala E,Auvinen A. Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients. Int J Cancer. 2006; 118: 10171021.
  • 45
    Tucker MA,Coleman CN,Cox RS,Varghese A,Rosenberg SA. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 1988; 318: 7681.
  • 46
    Bhatia S,Robison LL,Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996; 334: 745751.
  • 47
    Hancock SL,Hoppe RT. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol. 1996; 6: 225242.
  • 48
    Kattan MW,Leung DH,Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002; 20: 791796.
  • 49
    Weitz J,Antonescu CR,Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol. 2003; 21: 27192725.